Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Mexico Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 2.31 billion by 2028, growing at a CAGR of 3.30% during the forecast period (2023-2028). Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older ... Read More
-
Europe Insulin Pens Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 2.29 billion by 2028, growing at a CAGR of 1.45% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the European Insulin Pens Market. Type-1 diabetes patients are impacted more during Covid-19. ... Read More
-
Thailand Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 165 million by 2028, at a CAGR of 6.36% during the forecast period (2023-2028). The healthcare system was significantly disturbed and pressured during each phase of rapid COVID-19 infection. Several countries, notably the Thai ... Read More
-
Mexico Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 662 million by 2028, at a CAGR of 5.98% during the forecast period (2023-2028). The COVID-19 pandemic has had a notable impact on the diabetes care devices market. Diabetes is a chronic condition demanding ... Read More
-
New Zealand Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 839.07 million by 2028, at a CAGR of 4% during the forecast period (2023-2028). Type 1 diabetes was more likely to occur after being diagnosed with COVID-19. Young pediatric patients and older adult patients ... Read More
-
Italy Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 809.55 million by 2028, at a CAGR of 3.50% during the forecast period (2023-2028). The COVID-19 pandemic caused early fatalities during the first year of its existence, primarily in older people. The first nation ... Read More
-
India Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 1.94 billion by 2028, at a CAGR of 3.50% during the forecast period (2023-2028). Infections with COVID-19, which started about two years ago, have increased by almost 25% in India. India is regarded as ... Read More
-
New Zealand Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 495.73 million by 2028, at a CAGR of 3.30% during the forecast period (2023-2028). An individual's risk of infection, including other viral infections like the flu, is increased by diabetes. If they get COVID-19, ... Read More
-
Italy Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion by 2028, at a CAGR of 3% during the forecast period (2023-2028). Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Italy was ... Read More
-
Vietnam Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 241.05 million by 2028, growing at a CAGR of 3.70% during the forecast period (2023-2028). Vietnam has effectively stopped transmission of the COVID-19 outbreak since the outset, with no deaths for months. ... Read More
-
Japan Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 4.00 billion by 2028, growing at a CAGR of 3.60% during the forecast period (2023-2028). The COVID-19 pandemic has had a substantial impact on the diabetes drugs market. The prevalence of diabetes in people ... Read More
-
Europe Biosimilars Market Forecast to 2030 - Regional Analysis By Disease Indication (Cancer, Diabetes, Autoimmune Disease, and Other Disease Indication), Route of Administration (Intravenous, Subcutaneous, and Others), Drug Class (Granulocyte Colony-Stimulating Factor, Insulin, TNF Blockers and Monoclonal Antibodies, and Others), Distribution Channel (Hospital Pharmacies, Compounding Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region
... and Monoclonal Antibodies, and Others), Distribution Channel (Hospital Pharmacies, Compounding Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region The Europe biosimilars market is expected to grow from US$ 10,344.86 million in 2022 to US$ 1,15,125.91 ... Read More
-
Diabetic Food Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... predicted to expand in lockstep with the rising world population. Concurrently, the number of people suffering from chronic metabolic illnesses, notably diabetes, has increased significantly. As a result, the demand for diabetic food items has ... Read More
-
2023 Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders Global Market Size & Growth Report with Global Recession Risk Impact
... Growth Report covers market size, revenue, growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through 2022, with ... Read More
-
Insulin Delivery Device - Global Market Insights, Competitive Landscape, and Market Forecast - 2028
... Others), End-User (Homecare Settings, Diabetes Centers, Hospitals, and Others), and Geography is anticipated to expand at a significant CAGR forecast till 2028 due to rising prevalence of diabetes across the globe and rising awareness regarding ... Read More
-
UAE Intragastric Balloons Market, By Administration (Pill Form v/s Endoscopy), By Balloon Type (Single, Dual, Triple), By Filling Type (Saline Filled v/s Gas Filled), By Application (Obesity, Diabetes, Diet Control, Others), By End User (Hospitals &, Clinics, Ambulatory Surgical Centers, Others), By Region, Competition Forecast & Opportunities, 2027
... &, Clinics, Ambulatory Surgical Centers, Others), By Region, Competition Forecast & Opportunities, 2027 The UAE intragastric balloons market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the increasing ... Read More
-
Spain Self Diagnostics Market
... Pharmacies, Hospital Pharmacies, Hypermarket/Supermarket, E-Commerce Channels/Online Pharmacies), By Region, Competition Forecast, and Opportunities, 2028 Spain self diagnostics market is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028. The self diagnostics ... Read More
-
Condition Specific Report 2023
... over 150 charts covering 22 conditions such as brain health, healthy aging, beauty from within, heart health, diabetes, menopause, weight management - and more. This report showcases which consumer concerns will drive growth through 2026. ... Read More
-
Insulin Delivery Devices Market by Type (Insulin Pens [Reusable, Disposable], Insulin Pumps (Tethered, Tubeless), Insulin Syringes, Insulin Pen Needles (Standard, Safety)), End User (Hospitals & Clinics, Patients/Homecare) - Global Forecast to 2028
... delivery devices market is projected to reach USD 46.2 billion by 2028 from USD 30.8 billion in 2023, at a CAGR of 8.5% during the forecast period. Growth in the insulin delivery devices market is ... Read More
-
Injectable Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2028, at a CAGR of 7.55% during the forecast period (2023-2028). COVID-19 impacted the growth of the market studied. During the pandemic, companies were developing drugs and seeking collaborations and approvals to develop a vaccine ... Read More
-
Glucose Monitoring Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
... and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Glucose Monitoring pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
Insulin Delivery Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
... and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Insulin Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
Smart Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global smart medical devices market is witnessing remarkable growth, fueled by continuous advancements in digital health technologies and innovative customer-centric products. Smart medical devices utilize cutting-edge digital, networking, and sensor technologies to monitor, manage, ... Read More
-
Global Metabolism Drugs Market Size study & Forecast, by Drug Type (Antidiabetic Drugs, Lipid Lowering Drugs, Anti-Obesity Drugs, Thyroid Hormone Drugs, Others) by Indication (Diabetes, Hyperlipidaemia, Obesity, Hypothyroidism) and Regional Analysis, 2023-2030
... Market is valued approximately at USD 16.10 billion in 2022 and is anticipated to grow with a growth rate of more than 6.50% over the forecast period 2023-2030. A metabolism drug refers to a medication ... Read More
-
Lancet Market Size - By Type (Safety Lancets, Standard Lancets, Manually Activated Lancets, Automatically Activated Lancets), By Size (22G and Below, 23G-33G, Above 33G), By End-use - Global Forecast (2023-2032)
... exhibit 4.7% CAGR from 2023 to 2032, driven by the growing prevalence of diabetes worldwide. According to WHO, diabetes affects approximately 422 million individuals globally, with the majority residing in low- and middle-income nations. Each ... Read More
Research Assistance
